he big type 1 diabetes foundation JDRF this week launched a new financial vehicle to more nimbly invest in companies developing medicines or devices for type 1 diabetes.

The JDRF T1D Fund, as the vehicle is being called, launches with $42 million and aims to raise $80 million in its first two years. The new fund will focus on opportunities toward the later stages of product development. It will often take equity stakes in companies, or negotiate a share of future product royalties.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.